Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

MYL

Mylan NV (MYL)

Mylan NV
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:MYL
DateHeureSourceTitreSymboleSociété
06/05/202222h43Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:MYLMylan NV
29/09/202112h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MYLMylan NV
28/09/202115h28Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:MYLMylan NV
10/09/202123h02Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:MYLMylan NV
27/11/202023h01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)NASDAQ:MYLMylan NV
19/11/202023h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MYLMylan NV
16/11/202022h03Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:MYLMylan NV
06/11/202015h05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MYLMylan NV
06/11/202012h59PR Newswire (US)Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc.NASDAQ:MYLMylan NV
02/11/202013h30PR Newswire (US)Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for ViatrisNASDAQ:MYLMylan NV
30/10/202019h23Dow Jones NewsPfizer, Mylan Agreement With FTC Over Upjohn Deal, Clearing Way for November ClosingNASDAQ:MYLMylan NV
30/10/202018h39PR Newswire (US)Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and UpjohnNASDAQ:MYLMylan NV
15/09/202013h15PR Newswire (US)Mylan and Development Partner, Synthon, Win Significant European Patent Office Ruling Related to Copaxone® 40mg/mLNASDAQ:MYLMylan NV
15/09/202013h00PR Newswire (US)Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and UpjohnNASDAQ:MYLMylan NV
09/09/202019h07PR Newswire (US)Mylan to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare ConferenceNASDAQ:MYLMylan NV
09/09/202019h05PR Newswire (US)Mylan to Present at the BofA Securities Virtual Global Healthcare ConferenceNASDAQ:MYLMylan NV
08/09/202008h00PR Newswire (US)Mylan to Acquire Aspen's Thrombosis Business in EuropeNASDAQ:MYLMylan NV
31/08/202012h06Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:MYLMylan NV
31/08/202012h00PR Newswire (US)Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patien...NASDAQ:MYLMylan NV
29/08/202000h30PR Newswire (US)Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP ...NASDAQ:MYLMylan NV
19/08/202014h09Dow Jones NewsMylan Launches First U.S. Generic of Biogen MS Drug TecfideraNASDAQ:MYLMylan NV
19/08/202013h00PR Newswire (US)Mylan Brings Critical Access to the Multiple Sclerosis Community by Launching a More Affordable Treatment Option Through a Fi...NASDAQ:MYLMylan NV
13/08/202000h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MYLMylan NV
12/08/202015h00PR Newswire (US)Mylan and Sesame Workshop Partner to Provide Socio-Emotional Support Resources to Families Impacted by COVID-19NASDAQ:MYLMylan NV
06/08/202012h30PR Newswire (US)Mylan Reports Strong Second Quarter and First Half 2020 Results and Updates 2020 GuidanceNASDAQ:MYLMylan NV
22/07/202013h30PR Newswire (US)Mylan to Release Second Quarter 2020 Financial Results on Aug. 6, 2020NASDAQ:MYLMylan NV
10/07/202023h22Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MYLMylan NV
09/07/202014h31PR Newswire (US)Viatris Reveals Branding to Reflect New Company's Transformative StrategyNASDAQ:MYLMylan NV
09/07/202012h30PR Newswire (US)Mylan and Fujifilm Kyowa Kirin Biologics Announce U.S. FDA Approval of Hulio® (adalimumab-fkjp)NASDAQ:MYLMylan NV
07/07/202017h35PR Newswire (US)Mylan Initiates Voluntary Nationwide Recall of One Lot of Daptomycin for Injection, Due to the Presence of ParticulateNASDAQ:MYLMylan NV
 Showing the most relevant articles for your search:NASDAQ:MYL